Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Neuroprotective effect of sigma-1-receptor agonist 1,3-di-o-tolylguanidine in rotenone-induced model of Parkinson's disease in rats.
Journal: Metabolic brain disease
Published: August 12, 2025
Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson's Disease.
Journal: Neurochemical research
Published: March 01, 2023
Showing 1-2 of 2
Last Updated: 09/26/2026